Compound E, chemically designated as 209986-17-4, represents a significant exploration within the field of Alzheimer's disease research. This γ-secretase blocking agent was initially developed as a possible https://estelleanug795399.blogdigy.com/γ-secretase-inhibitor-compound-e-209986-17-4-64900645